MMP9 and Cognitive impairment: Studies have shown that MMP9 levels are elevated in the brains of patients with mid- to late-stage AD and increased MMP9 expression in the hippocampus may be involved in the development of Aβ-induced cognitive impairment and neurotoxicity (Hernandes-Alejandro et al., 2020).